Argonautic Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Argonautic Ventures/Activity

Argonautic Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· NOV 2025 – APR 2026Show all

Investment

Co-invested in Conxai's €5M seed round for agentic AI in construction technology.

Conxai

Conxai Argonautic Ventures

proptechconnect.comAPR 2026

APR 2026

Investment

Participated in ConsenSys Series D funding round as part of broader investor syndicate.

Consensys

Consensys Argonautic Ventures

businesswire.comDEC 2025

DEC 2025

Investment

Participated in Accipiter Biosciences' $12.7M seed round for de novo protein therapeutics, alongside Takeda, Flying Fish Partners, and others.

Accipiter Biosciences

Accipiter Biosciences Argonautic Ventures

geekwire.comNOV 6, 2025

globenewswire.com

NOV 6, 2025

Exit

Portfolio company Journeys Metabolic exited via acquisition.

Journeys Metabolic

Journeys MetabolicArgonautic Ventures

lawrenceevans.comNOV 2025

NOV 2025

Investment

Participated in ConCntric's $10M Series A funding for preconstruction management platform.

ConCntric

ConCntric Argonautic Ventures

globenewswire.comOCT 2025

OCT 2025